KELYA trades 21.6% below Wall Street's consensus target of $20.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes KELYA achieves its forward estimates and maintains a stable P/E multiple of 15.0x. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, Kelly Services, Inc. (KELYA) has a Wall Street consensus price target of $20.00, based on estimates from 5 covering analysts. With the stock currently trading at $16.45, this represents a potential upside of +21.6%. The company has a market capitalization of $570M.
Analyst price targets range from a low of $20.00 to a high of $20.00, representing a 0% spread in expectations. The median target of $20.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, KELYA trades at a trailing P/E of -2.3x and forward P/E of 15.0x. Analysts expect EPS to grow +114.1% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MANManpowerGroup Inc. | $2.7B | $57.37 | $54.43 | -5.1% | Hold | 15.8x | 29 |
 RHIRobert Half Inc. | $3.8B | $37.36 | $38.00 | +1.7% | Hold | 29.7x | 25 |
 ASGNASGN Incorporated | $1.4B | $32.27 | $34.75 | +7.7% | Hold | 8.9x | 13 |
 TBITrueBlue, Inc. | $298M | $9.81 | $9.50 | -3.2% | Buy | — | 10 |
 KFRCKforce Inc. | $929M | $52.07 | $59.00 | +13.3% | Hold | 20.5x | 10 |
 NSPInsperity, Inc. | $1.9B | $48.85 | $56.33 | +15.3% | Hold | 23.1x | 8 |
 CCRNCross Country Healthcare, Inc. | $428M | $13.25 | $12.09 | -8.8% | Hold | 143.2x | 14 |
 AMNAMN Healthcare Services, Inc. | $1.3B | $33.91 | $37.00 | +9.1% | Buy | 10.3x | 17 |
 HCSGHealthcare Services Group, Inc. | $1.5B | $21.25 | $26.50 | +24.7% | Hold | 17.7x | 15 |
 ADPAutomatic Data Processing, Inc. | $105.4B | $263.68 | $267.67 | +1.5% | Hold | 23.8x | 36 |
Quick answers to the most common questions about buying KELYA stock.
The consensus Wall Street price target for KELYA is $20, representing 21.6% upside from the current price of $16.45. With 5 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
KELYA has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $20 implies 21.6% upside from current levels.
With a forward P/E of 15.0228x, KELYA trades at a relatively low valuation. The consensus target of $20 implies 21.6% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $20 for KELYA, while the most conservative target is $20. The consensus of $20 represents the median expectation. These targets typically reflect 12-month expectations.
KELYA is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month KELYA stock forecast based on 5 Wall Street analysts shows a consensus price target of $20, with estimates ranging from $20 (bear case) to $20 (bull case). The median consensus rating is "Buy".
KELYA trades at a forward P/E ratio of 15.0x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on KELYA, with a "Buy" consensus rating and $20 price target (21.6% upside). 3 of 5 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
KELYA analyst price targets range from $20 to $20, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $20 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.